T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
iShares MSCI EAFE ETF
EFA
$80.3B
| $1.72M | ﹤0.01% |
26,761
-275,100
| -91% | -$17.3M |
|
1602
Huntington Ingalls Industries
HII
$12.8B
| $1.72M | ﹤0.01% |
12,254
-570
| -4% | -$73.4K |
|
1603
AMC Global Media
AMCX
$496M
| $1.7M | ﹤0.01% |
22,115
+832
| +4% | +$57.5K |
|
1604
Albemarle
ALB
$15.4B
| $1.68M | ﹤0.01% |
31,700
+2,100
| +7% | +$115K |
|
1605
Essential Utilities
WTRG
$11.5B
| $1.67M | ﹤0.01% |
63,228
-1,600
| -2% | -$42.6K |
|
1606
Raymond James Financial
RJF
$34.8B
| $1.66M | ﹤0.01% |
43,919
+867
| +2% | +$32.4K |
|
|
RGLS
1607
DELISTED
Regulus Therapeutics
RGLS
| $1.65M | ﹤0.01% |
+810
| New | +$1.76M |
|
|
NRF
1608
DELISTED
NorthStar Realty Finance Corp.
NRF
| $1.64M | ﹤0.01% |
45,339
+85
| +0.2% | +$3.15K |
|
1609
Brown-Forman Class A
BF.A
$13.1B
| $1.63M | ﹤0.01% |
45,000
| – | – |
|
1610
Service Corp International
SCI
$11.3B
| $1.62M | ﹤0.01% |
62,331
| – | – |
|
1611
SEI Investments
SEIC
$12.8B
| $1.61M | ﹤0.01% |
36,462
-1,502
| -4% | -$63K |
|
|
UFS
1612
DELISTED
DOMTAR CORPORATION (New)
UFS
| $1.61M | ﹤0.01% |
34,782
| – | – |
|
|
ODP
1613
DELISTED
ODP
ODP
| $1.61M | ﹤0.01% |
17,461
+1,090
| +7% | +$97.1K |
|
|
WOOF
1614
DELISTED
VCA Inc.
WOOF
| $1.6M | ﹤0.01% |
29,200
| – | – |
|
1615
Arrow Electronics
ARW
$10.6B
| $1.59M | ﹤0.01% |
26,075
+1,200
| +5% | +$71.4K |
|
1616
Aecom
ACM
$8.19B
| $1.59M | ﹤0.01% |
51,531
| – | – |
|
|
NEWS
1617
DELISTED
NewStar Financial, Inc.
NEWS
| $1.58M | ﹤0.01% |
134,691
| – | – |
|
1618
Amkor Technology
AMKR
$14.3B
| $1.56M | ﹤0.01% |
176,653
-23,800
| -12% | -$193K |
|
|
HOUS
1619
DELISTED
Anywhere Real Estate
HOUS
| $1.55M | ﹤0.01% |
34,054
+4,640
| +16% | +$214K |
|
1620
American Financial Group
AFG
$12.1B
| $1.54M | ﹤0.01% |
24,060
+1,200
| +5% | +$74.3K |
|
|
SRC
1621
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $1.54M | ﹤0.01% |
28,433
| – | – |
|
1622
SLM Corp
SLM
$5.22B
| $1.53M | ﹤0.01% |
164,729
-58,069
| -26% | -$546K |
|
1623
Crown Holdings
CCK
$12.9B
| $1.52M | ﹤0.01% |
28,238
+88
| +0.3% | +$4.37K |
|
1624
Cracker Barrel
CBRL
$1.31B
| $1.52M | ﹤0.01% |
10,000
+600
| +6% | +$84.8K |
|
1625
Oshkosh
OSK
$9.41B
| $1.51M | ﹤0.01% |
31,041
+90
| +0.3% | +$4.12K |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.